Gestational Diabetes Mellitus: To Screen or Not to Screen?

نویسندگان

  • David Simmons
  • Robert G. Moses
چکیده

D iscussion about gestational diabetes mellitus (GDM) is slowly creating traction on the best way forward. Recent evidence has confirmed that there is a continuum of risk for adverse maternal and fetal outcomes as the maternal glucose level rises (1,2). There is an increasing number of studies supporting the importance of fuel-mediated teratogenesis, including epigenetic influences, that are leading to intergenerational transmission of type 2 diabetes, features of themetabolic syndrome, and overall amplification of the current diabetes pandemic (3,4). Treatment of women with GDM, variously defined, improves outcomes (5,6). New consensus guidelines for the diagnosis of GDM have been recommended by the International Association of the Diabetes and Pregnancy Study Groups (IADPSG) (7) based on the risk of adverse pregnancy outcomes, rather than the long-termmaternal diabetes risk, alignment with diabetes complication risks outside of pregnancy, workload, or local consensus (8). Although there has been a vigorous debate about the validity of the IADPSG diagnostic criteria, less attention has been paid to the other recommendations of universal testing and using a one-stage diagnostic glucose tolerance test (GTT) without preliminary risk factor screening and/or a glucose challenge test (GCT). The National Institutes of Health has recently highlighted the need for action toward standardization of GDM diagnostic criteria, but has not advocated adopting any of the IADPSG recommendations. Thus, there remains a recommendation to continue with risk factor screening and the use of a GCT (9). In this issue ofDiabetes Care, Avalos et al. (10) haveuseddata from theATLANTICDIP study to retrospectively examine risk factor prediction of GDM, using different combinations of risk factors, in amainly European population whowere offered universal testing. The prevalence of GDM using the IADPSG criteria was 12.4%. Depending on the combination of risk factors used, 54–76% of women had at least one risk factor present. However, the prevalence of GDM among women with no risk factors ranged from 2.7 to 5.4%, by itself not an inconsiderable figure. Women diagnosed with GDM, but without risk factors, had worse pregnancy outcomes than women with normal glucose tolerance (10), supporting the findings in a recent French study (11). In another recent European report, 20% of women diagnosed with GDM had no defined risk factors (12). At one stage it was advised that women with low risk factors need not to be tested (13). However, reports from North America (14) and New Zealand (15) found that a large proportion (90 and 97.9%, respectively) of pregnant women would still require testing. A report from Australia found that 80% of women would still require testing and women with low risk factors still constituted 10% of the GDM population (16). In the developed world with growing epidemics of obesity and diabetes, the majority of women in most populations will now have some risk factors depending on the criteria used (11,14–16). Clearly, women with no risk factors can develop GDM, and the outcomes are no different (17) in women identified by risk factors. Once clinicians have to make decisions in the screening process, it is more open to error, delays, and problems. We already know that where a variety of risk factors with cutoffs are used, busy clinicians will not necessarily recall who is to be screened (18), and this is associated with reduced penetration of screening among those at high risk (19). From a systems perspective, universal blood testingmakes the detection of GDM in those at highest risk more likely to happen in day-to-day clinical practice. Another method of screening involves a GCT. The origins of the GCT would require a forensic endocrinologist to resolve, and what clinical evidence was advanced at the time to support such a step would be interesting to contemplate. Given that only 44% of women in the study by Avalos et al. (10) accepted the offer of a one-stage test, what may have been the acceptance of a two-stage procedure? The GCT will inevitablydelay thediagnosis ofGDMand therefore treatment (20). However, the most serious concern about using a GCT is the no-show rate for the definitive GTT for women who are abnormal. In the Toronto Tri-Hospital GestationalDiabetes Project, 10%ofwomen didnot proceedwith theGTT (21); in aNew Zealand study, the rate was 23% (22); and, in hopefully a worst case scenario, a recent North American report found that only 36% attended the GTT (23). Screening on the basis of risk factors will require most women to be tested and inevitably and knowinglymiss womenwith GDM. GCT screeningmisses many of those with GDM with a modestly elevated fasting glucose and runs the risk of missing other womenwith GDMbecause of the inevitable no-show rate. It is open to speculation how the combination of risk factor screening and a GCT may compound the number of missed diagnoses. It is difficult to find any health advantages in screening for GDM (rather than going straight to a diagnostic test), either on the basis of risk factors and/or aGCT.There are several health disadvantages. Although not explicitly stated, the only possible presumed advantage of screening is to reduce costs, and on this aspect there is a dearth of data (24,25). The direct and immediate costs of a GCT/GTT will vary with different health systems. In the overall costs of delivering obstetric services, this is likely to be minor, especially if the initial GTT fasting glucose can be used to decidewhether a full GTT is required (26). There are some populations where women are unlikely to attend fasting (e.g., rural India), but in such cases, a two-step test is also likely to be associated with poor attendance at the second step and a one-step diagnostic step, of any kind, is preferred (27). Although some uniformity would be desirable, screening based on risk factors would involve defining risk factors in the particular population and not just importing from a possibly irrelevant or unrepresentative population. Training and audits would have to be conducted to ensure that

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

تحلیل هزینه روشهای غربالگری و تشخیصی در دیابت بارداری

Background: Estimation of cost effectiveness and cost benefit are intrinsic to the design and evaluation of healthcare systems. The aim of most studies of gestational diabetes screening has been to modulate screening parameters to reduce the eligible population and therefore costs. We analysed the findings of a cross-sectional study of gestational diabetes mellitus carried out in Tehran to dete...

متن کامل

Screening for Gestational Diabetes Mellitus (GDM)

While it is not possible to issue a guideline for the best method of screening, the use of a 75 g OGTT instead of an OGCT as first line of testing for women from high risk populations will avoid the inconvenience of further testing for both women and staff. Afternoon or evening clinics may be better advised to screen women using an OGCT (rather than an OGTT) because women are not required to fa...

متن کامل

Fasting Blood Sugar, Glucose Challenge Test and One- Two Hour Glucose Tolerance Test in Diagnosis of Gestational Diabetes in Women without Risk Factor

Objective: Gestational diabetes mellitus (GDM) is the most common metabolic disorder during pregnancy. This study aimed to compare the prevalence of GDM positive screening tests with Fasting Blood Sugar (FBS) and Glucose Challenge Test (GCT) in pregnant women without risk factors in Esfarayn, Iran. Materials and Methods: This descriptive study was conducted on 997 pregnant women, who were refe...

متن کامل

Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios: are they useful for predicting gestational diabetes mellitus during pregnancy?

OBJECTIVE We aimed to investigate whether the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) could be utilized to screen for gestational diabetes mellitus (GDM). SUBJECTS AND METHODS NLR and PLR were assessed by retrospective analysis of 762 healthy and pregnant women with GDM. The patients were stratified into four groups, as follows: GDM (n=144), impaired glucos...

متن کامل

Multifactorial therapy: microvascular outcomes in screen-detected diabetes Cost-effectiveness of gestational diabetes screening

Multifactorial therapy: microvascular outcomes in screen-detected diabetes Cost-effectiveness of gestational diabetes screening Excess mortality still high in Finnish diabetics Acute coronary syndrome and glucose metabolism disorders Diabetes foot risk stratification and mortality Predictors of lifestyle intervention success Integrating primary and secondary care Brown rice improves glucose and...

متن کامل

بررسی شیوع دیابت حاملگی در جامعه شهری شاهرود در سال 79-1378

Background and purpose : Gestational diabetes mellitus is referred to the intolerance of carbohydrates with different degrees in which its onset or primary diagnosis is in the gestational period and generally occurring in 1-14% of the pregnancies. Çonsidering the importance of prognosis, aim of this study was to identify the women facing gestational diabetes and to determine the prevalence wh...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:

دوره 36  شماره 

صفحات  -

تاریخ انتشار 2013